インスリンペンの市場規模、シェア、予測、動向：タイプ別、糖尿病タイプ別、流通別、ヘルスケア環境別-2031年までの世界予測

世界のインスリンペン市場は、2024年から2031年までのCAGR6.7%で、2031年までに67億3,000万米ドル超に達すると予測されます。

当レポートは、広範な2次調査と1次調査、および市場シナリオの詳細な分析を経て、主要な市場促進要因、抑制要因、課題、および機会の分析から構成されています。糖尿病有病率の増加、インスリンペンの技術的進歩、薬剤の自己投与に対する需要の高まり、糖尿病啓発プログラムの高まりなどが成長要因です。しかし、インスリンペンの高コスト、インスリンペンの代替品の入手可能性、患者の注射針への不安などがこの市場の成長を抑制しています。

さらに、バイアルやシリンジよりもインスリンペンへの嗜好が高まっていること、新興経済国、インスリン製造企業による提携や協力関係は、この市場で事業を展開するプレーヤーに成長機会をもたらすと期待されています。しかし、新興諸国における認識や知識の不足、発展途上国におけるヘルスケアへの限られたアクセスは、市場成長に影響を与える主要な課題です。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場成長の要因

• 概要
• 促進要因
  • 糖尿病の有病率の増加
  • インスリンペンの技術的進歩
  • 薬剤の自己投与に対する需要の高まり
  • 糖尿病啓発プログラムの増加
• 抑制要因
  • インスリンペンの高コスト
  • インスリンペンの代替品の入手可能性
  • 患者の注射針に対する不安
• 機会
  • バイアルやシリンジよりもインスリンペンへの嗜好の高まり
  • 新興経済国
  • パートナーシップとコラボレーション
• 課題
  • 新興諸国における認識と知識の欠如
  • 新興諸国におけるヘルスケアへのアクセス制限
• 動向
  • スマートインスリンペン
  • プレフィルドインスリンペン
• 要因分析
• 規制分析
  • 米国
  • カナダ
  • 欧州
  • 中国
  • 日本
  • インド
  • ラテンアメリカ
  • 中東
• 価格分析
• 親/隣接市場分析
• ポーターのファイブフォース分析

第5章 インスリンペン市場評価：タイプ別

• 概要
• 使い捨てインスリンペン
• 再利用可能インスリンペン
• スマートインスリンペン
  • Bluetooth接続
  • 近距離無線通信（NFC）コネクティビティ

第6章 インスリンペン市場評価：用途別

• 概要
• 1型糖尿病
• 2型糖尿病

第7章 インスリンペン市場評価：流通チャネル別

• 概要
• 病院薬局
• 小売薬局
• オンライン/eコマースプラットフォーム

第8章 インスリンペン市場評価：ヘルスケア環境別

• 概要
• 在宅医療
• 病院・診療所
• 長期療養環境

第9章 インスリンペン市場評価：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • オーストリア
  • オランダ
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ

第10章 競合分析

• 概要
• 主要成長戦略
• 競合ベンチマーキング
• 競合ダッシュボード
  • 業界リーダー
  • 市場差別化要因
  • 先行企業
  • 新興企業
• 主要企業の市場シェア分析／市場ランキング（2023年）

第11章 企業プロファイル（事業概要、財務概要、製品ポートフォリオ、戦略的展開）

• Novo Nordisk A/S
• Eli Lilly and Company
• Sanofi S.A.
• Biocon Limited
• Becton, Dickinson and Company
• Ypsomed AG
• Owen Mumford Limited
• Medtronic plc
• Emperra GmbH E-Health Technologies
• pendiq GmbH
• Jiangsu Delfu medical device Co. Ltd

（注：上位5社のSWOT分析を掲載）

第12章 付録

LIST OF TABLES

• Table 1 Global Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 2 Global Disposable Insulin Pens Market, by Country/Region , 2022-2031 (USD Million)
• Table 3 Global Disposable Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
• Table 4 Global Reusable Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
• Table 5 Global Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 6 Global Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
• Table 7 Global Bluetooth Connected Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
• Table 8 Global Near Field Communication (NFC) Smart Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
• Table 9 Global Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 10 Global Insulin Pens Market for Type 1 Diabetes, by Country/Region, 2022-2031 (USD Million)
• Table 11 Global Insulin Pens Market for Type 2 Diabetes, by Country/Region, 2022-2031 (USD Million)
• Table 12 Global Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 13 Global Insulin Pens Market for Hospital Pharmacies, by Country/Region, 2022-2031 (USD Million)
• Table 14 Global Insulin Pens Market for Retail Pharmacies, by Country/Region, 2022-2031 (USD Million)
• Table 15 Global Insulin Pens Market for Online/E-commerce Platforms, by Country/Region, 2022-2031 (USD Million)
• Table 16 Global Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 17 Global Insulin Pens Market for Home Care, by Country/Region, 2022-2031 (USD Million)
• Table 18 Global Insulin Pens Market for Hospitals & Clinics, by Country/Region, 2022-2031 (USD Million)
• Table 19 Global Insulin Pens Market for Long-Term Care Settings, by Country/Region, 2022-2031 (USD Million)
• Table 20 Global Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
• Table 21 North America: Insulin Pens Market, by Country, 2022-2031 (USD Million)
• Table 22 North America: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 23 North America: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 24 North America: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 25 North America: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 26 North America: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 27 U.S.: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 28 U.S.: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 29 U.S.: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 30 U.S.: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 31 U.S.: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 32 Canada: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 33 Canada: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 34 Canada: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 35 Canada: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 36 Canada: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 37 Europe: Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
• Table 38 Europe: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 39 Europe: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 40 Europe: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 41 Europe: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 42 Europe: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 43 Germany: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 44 Germany: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 45 Germany: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 46 Germany: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 47 Germany: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 48 France: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 49 France: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 50 France: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 51 France: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 52 France: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 53 Italy: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 54 Italy: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 55 Italy: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 56 Italy: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 57 Italy: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 58 Spain: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 59 Spain: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 60 Spain: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 61 Spain: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 62 Spain: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 63 Austria: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 64 Austria: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 65 Austria: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 66 Austria: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 67 Austria: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 68 Netherlands: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 69 Netherlands: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 70 Netherlands: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 71 Netherlands: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 72 Netherlands: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 73 Rest of Europe: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 74 Rest of Europe: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 75 Rest of Europe: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 76 Rest of Europe: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 77 Rest of Europe: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 78 Asia-Pacific: Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
• Table 79 Asia-Pacific: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 80 Asia-Pacific: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 81 Asia-Pacific: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 82 Asia-Pacific: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 83 Asia-Pacific: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 84 China: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 85 China: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 86 China: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 87 China: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 88 China: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 89 Japan: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 90 Japan: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 91 Japan: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 92 Japan: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 93 Japan: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 94 India: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 95 India: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 96 India: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 97 India: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 98 India: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 99 South Korea: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 100 South Korea: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 101 South Korea: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 102 South Korea: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 103 South Korea: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 104 Australia: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 105 Australia: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 106 Australia: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 107 Australia: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 108 Australia: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 109 Rest of Asia-Pacific: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 110 Rest of Asia-Pacific: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 111 Rest of Asia-Pacific: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 112 Rest of Asia-Pacific: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 113 Rest of Asia-Pacific: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 114 Latin America: Insulin Pens Market, by Country/Region, 2022-2031 (USD Million)
• Table 115 Latin America: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 116 Latin America: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 117 Latin America: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 118 Latin America: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 119 Latin America: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 120 Brazil: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 121 Brazil: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 122 Brazil: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 123 Brazil: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 124 Brazil: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 125 Mexico: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 126 Mexico: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 127 Mexico: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 128 Mexico: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 129 Mexico: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 130 Rest of Latin America: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 131 Rest of Latin America: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 132 Rest of Latin America: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 133 Rest of Latin America: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 134 Rest of Latin America: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 135 Middle East & Africa: Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 136 Middle East & Africa: Smart Insulin Pens Market, by Type, 2022-2031 (USD Million)
• Table 137 Middle East & Africa: Insulin Pens Market, by Application, 2022-2031 (USD Million)
• Table 138 Middle East & Africa: Insulin Pens Market, by Distribution Channel, 2022-2031 (USD Million)
• Table 139 Middle East & Africa: Insulin Pens Market, by Healthcare Setting, 2022-2031 (USD Million)
• Table 140 Recent Developments, by Company, 2020-2024

LIST OF FIGURES

• Figure 1 Research Process
• Figure 2 Key Secondary Sources
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
• Figure 6 Market Size Estimation
• Figure 7 Global Insulin Pens Market, by Type, 2024 VS. 2031 (USD Million)
• Figure 8 Global Insulin Pens Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 9 Global Insulin Pens Market, by Distribution Channel, 2024 VS. 2031 (USD Million)
• Figure 10 Global Insulin Pens Market, by Healthcare Setting, 2024 VS. 2031 (USD Million)
• Figure 11 Global Insulin Pens Market, by Geography
• Figure 12 Impact Analysis: Insulin Pens Market
• Figure 13 Global Insulin Pens Market, by Type, 2024 VS. 2031 (USD Million)
• Figure 14 Global Insulin Pens Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 15 Global Insulin Pens Market, by Distribution Channel, 2024 VS. 2031 (USD Million)
• Figure 16 Global Insulin Pens Market, by Healthcare Setting, 2024 VS. 2031 (USD Million)
• Figure 17 Global Insulin Pens Market, by Geography, 2024 VS. 2031 (USD Million)
• Figure 18 North America: Insulin Pens Market Snapshot
• Figure 19 Europe: Insulin Pens Market Snapshot
• Figure 20 Asia-Pacific: Insulin Pens Market Snapshot
• Figure 21 Latin America: Insulin Pens Market Snapshot
• Figure 22 Key Growth Strategies Adopted by Leading Players, 2020-2024
• Figure 23 Global Insulin Pens Market: Competitive Benchmarking, by Type
• Figure 24 Global Insulin Pens Market: Competitive Benchmarking, by Geography
• Figure 25 Global Insulin Pens Market: Competitive Dashboard
• Figure 26 Global Insulin Pens Market: Market Share Analysis/Market Ranking By Key Players, 2023
• Figure 27 Novo Nordisk A/S: Financial Overview (2023)
• Figure 28 Eli Lilly and Company: Financial Overview (2023)
• Figure 29 Sanofi S.A.: Financial Overview (2023)
• Figure 30 Biocon Limited: Financial Overview (2023)
• Figure 31 Becton, Dickinson and Company: Financial Overview (2023)
• Figure 32 Ypsomed AG: Financial Overview (2023)
• Figure 33 Medtronic plc: Financial Overview (2023)

Insulin Pens Market Size, Share, Forecast, & Trends Analysis by Type (Disposable, Reusable, Smart [Bluetooth, NFC]) Diabetes Type (Type 1, Type 2) Distribution (Hospital, Retail Pharmacies, E-commerce) Healthcare Setting-Global Forecast to 2031

The global insulin pens market is projected to reach over $6.73 billion by 2031 at a CAGR of 6.7% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the increasing prevalence of diabetes, technological advancements in insulin pens, rising demand for self-administration of drugs, and rising diabetes awareness programs. However, the high cost of insulin pens, the availability of alternatives to insulin pens, and needle anxiety in patients restrain the growth of this market.

Furthermore, the rising preference for insulin pens over vials and syringes, emerging economies, and partnerships and collaborations by insulin manufacturing companies are expected to generate growth opportunities for the players operating in this market. However, lack of awareness and knowledge in developing countries and limited access to healthcare in developing countries are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global insulin pens market are Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Biocon Limited (India), Becton, Dickinson and Company (U.S.), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), Medtronic plc (Ireland), Emperra GmbH E-Health Technologies (Germany), pendiq GmbH (Germany), and Jiangsu Delfu medical device Co., Ltd (China).

Among all the types studied in this report, the disposable insulin pens segment is projected to register the highest CAGR of over 7.0% during the forecast period of 2024-2031. The high growth of this segment is attributed to the benefits offered by disposable insulin pens, such as their ability to cause less pain during administration. They come with a prefilled insulin cartridge loaded into the pen, and the entire product can be discarded after the cartridge is finished, minimizing the chances of infections.

Among all the applications studied in this report, in 2024, the type 1 diabetes segment is expected to account for the largest share of the insulin pens market. The large market share can be attributed to the increasing number of insulin-dependent patients and the rising number of type 1 diabetes cases. For instance, according to the International Diabetes Federation (IDF) data, in 2022, 8.75 million lived with type 1 diabetes globally. Out of which 1.52 million of these people were under 20 years old. Thus, the increasing number of type 1 diabetes cases drives the growth of this segment.

Among all the distribution channels studied in this report, in 2024, the distribution channel segment is expected to account for the largest share of the insulin pens market. Retail pharmacies often stock a diverse selection of insulin pens of different types. The increasing consumer demand for insulin pens and the opportunity for customers to inspect the product before making a purchase are the factors driving the growth of this segment.

Among all the healthcare settings studied in this report, in 2024, the home care segment is expected to account for the largest share of over 51.2% of the insulin pens market. The large market share of this segment can be attributed to the increasing development and adoption of home care devices due to their convenience, precision, and accuracy. Additionally, there has been a growing focus among companies to raise awareness about diabetes, which has led to increased adoption of insulin pens in home care settings.

An in-depth analysis of the geographical scenario of the global insulin pens market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 37.8% of the insulin pens market. In the region in 2024, the U.S. is expected to account for the largest share of the insulin pens market in North America. The large share of the country is attributed to the presence of major insulin pen companies such as Eli Lilly and Company (U.S.) and Becton, Dickinson and Company (U.S.), increasing healthcare expenditure, rising demand for self-administration of drugs, and rising number of diabetes cases in this region are some of the major factors driving the growth of the region.

Scope of the Report:

Insulin Pens Market Assessment-by Type

• Disposable Insulin Pens
• Reusable Insulin Pens
• Smart Insulin Pens
  • Bluetooth Connectivity
  • Near Field Communication (NFC) Connectivity

Insulin Pens Market Assessment-by Application

• Type 1 Diabetes
• Type 2 Diabetes

Insulin Pens Market Assessment-by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online/E-commerce Platforms

Insulin Pens Market Assessment-by Healthcare Setting

• Home Care
• Hospitals & Clinics
• Long-term Care Settings

Insulin Pens Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Austria
  • Netherlands
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Factors Affecting Market Growth

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Increasing Prevalence of Diabetes
  • 4.2.2. Technological Advancements in Insulin Pens
  • 4.2.3. Rising Demand for Self-Administration of Drugs
  • 4.2.4 Rising Diabetes Awareness Programs
• 4.3. Restraints
  • 4.3.1. High Cost of Insulin Pens
  • 4.3.2. Availability of Alternatives to Insulin Pens
  • 4.3.3. Needle Anxiety in Patients
• 4.4. Opportunities
  • 4.4.1. Rising Preference for Insulin Pens over Vials and Syringes
  • 4.4.2. Emerging Economies
  • 4.4.3. Partnerships and Collaborations
• 4.5. Challenges
  • 4.5.1. Lack of Awareness and Knowledge in Developing Countries
  • 4.5.2. Limited Access to Healthcare in Developing Countries
• 4.6. Trends
  • 4.6.1. Smart Insulin Pens
  • 4.6.2. Prefilled Insulin Pens
• 4.7. Factor Analysis
• 4.8. Regulatory Analysis
  • 4.8.1. U.S.
  • 4.8.2. Canada
  • 4.8.3. Europe
  • 4.8.4. China
  • 4.8.5. Japan
  • 4.8.6. India
  • 4.8.7. Latin America
  • 4.8.8. Middle East
• 4.9. Pricing Analysis
• 4.10. Parent/Adjacent Market Analysis
• 4.11. Porter's Five Forces Analysis

5. Insulin Pens Market Assessment-by Type

• 5.1. Overview
• 5.2. Disposable Insulin Pens
• 5.3. Reusable Insulin Pens
• 5.4. Smart Insulin Pens
  • 5.4.1. Bluetooth Connectivity
  • 5.4.2. Near Field Communication (NFC) Connectivity

6. Insulin Pens Market Assessment-by Application

• 6.1. Overview
• 6.2. Type 1 Diabetes
• 6.3. Type 2 Diabetes

7. Insulin Pens Market Assessment-by Distribution Channel

• 7.1. Overview
• 7.2. Hospital Pharmacies
• 7.3. Retail Pharmacies
• 7.4. Online/E-commerce Platforms

8. Insulin Pens Market Assessment-by Healthcare Setting

• 8.1. Overview
• 8.2. Home Care
• 8.3. Hospitals & Clinics
• 8.4. Long-Term Care Settings

9. Insulin Pens Market Assessment-by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Austria
  • 9.3.7. Netherlands
  • 9.3.8. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. Japan
  • 9.4.2. China
  • 9.4.3. India
  • 9.4.4. Australia
  • 9.4.5. South Korea
  • 9.4.6. Rest of Asia-Pacific
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America
• 9.6. Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies
• 10.5. Market Share Analysis/Market Rankings of Key Players (2023)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

• 11.1. Novo Nordisk A/S
• 11.2. Eli Lilly and Company
• 11.3. Sanofi S.A.
• 11.4. Biocon Limited
• 11.5. Becton, Dickinson and Company
• 11.6. Ypsomed AG
• 11.7. Owen Mumford Limited
• 11.8. Medtronic plc
• 11.9. Emperra GmbH E-Health Technologies
• 11.10. pendiq GmbH
• 11.11. Jiangsu Delfu medical device Co. Ltd

(Note: SWOT analysis of the top 5 companies will be provided.)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports